Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hybrid closed-loop insulin therapy has shown promise for management of type 1 diabetes during pregnancy; however, its efficacy is unclear. METHODS: In this multicenter, controlled trial, we randomly assigned pregnant women with type 1 diabetes and a glycated hemoglobin level of at least 6.5% at nine sites in the United Kingdom to receive standard insulin therapy or hybrid closed-loop therapy, with both groups using continuous glucose monitoring. The primary outcome was the percentage of time in the pregnancy-specific target glucose range (63 to 140 mg per deciliter [3.5 to 7.8 mmol per liter]) as measured by continuous glucose monitoring from 16 weeks' gestation until delivery. Analyses were performed according to the intention-to-treat principle. Key secondary outcomes were the percentage of time spent in a hyperglycemic state (glucose level >140 mg per deciliter), overnight time in the target range, the glycated hemoglobin level, and safety events. RESULTS: A total of 124 participants with a mean (±SD) age of 31.1±5.3 years and a mean baseline glycated hemoglobin level of 7.7±1.2% underwent randomization. The mean percentage of time that the maternal glucose level was in the target range was 68.2±10.5% in the closed-loop group and 55.6±12.5% in the standard-care group (mean adjusted difference, 10.5 percentage points; 95% confidence interval [CI], 7.0 to 14.0; P<0.001). Results for the secondary outcomes were consistent with those of the primary outcome; participants in the closed-loop group spent less time in a hyperglycemic state than those in the standard-care group (difference, -10.2 percentage points; 95% CI, -13.8 to -6.6); had more overnight time in the target range (difference, 12.3 percentage points; 95% CI, 8.3 to 16.2), and had lower glycated hemoglobin levels (difference, -0.31 percentage points; 95% CI, -0.50 to -0.12). Little time was spent in a hypoglycemic state. No unanticipated safety problems associated with the use of closed-loop therapy during pregnancy occurred (6 instances of severe hypoglycemia, vs. 5 in the standard-care group; 1 instance of diabetic ketoacidosis in each group; and 12 device-related adverse events in the closed-loop group, 7 related to closed-loop therapy). CONCLUSIONS: Hybrid closed-loop therapy significantly improved maternal glycemic control during pregnancy complicated by type 1 diabetes. (Funded by the Efficacy and Mechanism Evaluation Program; AiDAPT ISRCTN Registry number, ISRCTN56898625.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only one AID system is approved for use during pregnancy, and it has been shown to improve time in the target glucose range of 3•5-7•8 mmol/L without increasing the risk of hypoglycaemia.104”
From The future of type 1 diabetes therapy (2025) · cites this paper as [104]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Improvements have been especially notable in vulnerable populations, such as young children 103 and pregnant women with type 1 diabetes.104”
From The future of type 1 diabetes therapy (2025) · cites this paper as [104]
In the citing paper
“The secondary outcomes were also met, with less time spent above range (>140 mg/dL) in the AID group, greater overnight time in target range, and lower A1C (236).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [236]
In the citing paper
“Recent data have shown the clinical benefits and safety of AID use, even though only one study used an AID system with a pregnancyspecific glycemic target.”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [236]
In the citing paper
“The primary outcome of time spent in the pregnancy-specific target range of 63-140 mg/dL was found to be 10.5% higher in the AID group versus standard care (P < 0.001).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [236]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationFeig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Self-citationEvers, I. M., de Valk, H. W., & Visser, G. H. A. (2004) · BMJ · doi:10.1136/bmj.38043.583160.ee · Cited by 775
Per-Protocol Analyses of Pragmatic Trials
Hernán, M. A., & Robins, J. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmsm1605385 · Cited by 660
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443
Self-citationMurphy, H. R., Howgate, C., O'Keefe, J., Myers, J., Morgan, M., Coleman, M. A., Jolly, M., Valabhji, J., Scott, E. M., Knighton, P., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30406-x · Cited by 346
Self-citationClosed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes
Stewart, Z. A., Wilinska, M. E., Hartnell, S., Temple, R. C., Rayman, G., Stanley, K. P., Simmons, D., Law, G. R., Scott, E. M., Hovorka, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602494 · Cited by 279
Self-citationRandomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes
Ware, J., Allen, J. M., Boughton, C. K., Wilinska, M. E., Hartnell, S., Thankamony, A., de Beaufort, C., Schierloh, U., Fröhlich-Reiterer, E., Mader, J. K., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2111673 · Cited by 222
Self-citationTrial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes
Wadwa, R. P., Reed, Z. W., Buckingham, B. A., DeBoer, M. D., Ekhlaspour, L., Forlenza, G. P., Schoelwer, M., Lum, J., Kollman, C., Beck, R. W., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2210834 · Cited by 191
Self-citationStewart, Z. A., Wilinska, M. E., Hartnell, S., O’Neil, L. K., Rayman, G., Scott, E. M., Barnard, K., Farrington, C., Hovorka, R., & Murphy, H. R. (2018) · Diabetes Care · doi:10.2337/dc17-2534 · Cited by 168
Self-citation
Cited by
Items 101–200 of 254
Szadkowska, A., Chobot, A. P., Głowińska‐Olszewska, B., Jarosz-Chobot, P. A., Mianowska, B., Myśliwiec, M., Szypowska, A., Zubkiewicz‐Kucharska, A., & Walczak, M. (2024) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2024.144041 · Cited by 8
Ryan, L. W. K., Weiying, L., Wright, A., & Tan, L. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009507189 · Cited by 4
Varughese, M. S., Nayak, A., & Varadhan, L. (2025) · Eye · doi:10.1038/s41433-025-03730-4 · Cited by 4
Liarakos, A. L., Panagiotou, G., Chondronikola, M., & Wilmot, E. G. (2025) · Life · doi:10.3390/life15101579 · Cited by 6
Managing diabetes across female reproductive stages
Mauricio, D., Gratacòs, M., & Franch‐Nadal, J. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.02.003 · Cited by 4
Sight-Threatening Diabetic Retinopathy During and After Pregnancy—A Nationwide Matched-Cohort Study
Larsson, J., Stokholm, L., Bek, T., Andersen, N., Andresen, J., Hajari, J. N., Heegaard, S., Højlund, K., Kawasaki, R., Möller, S., et al. (2025) · Diabetes Care · doi:10.2337/dc25-0758 · Cited by 6
King, J., Buschur, E., Snell-Bergeon, J., Pyle, L., Dungan, K., Garcetti, R., Nease, E., Bartholomew, A., Johnson, C., & Polsky, S. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241260050 · Cited by 3
Yang, Q., Hao, J., Cui, H., Yang, Q., Sun, F., & Zeng, B. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02454-x · Cited by 3
Christiansen, K., Nørgaard, S. K., Nørgaard, K., Clausen, T. D., Damm, P., Mathiesen, E. R., & Ringholm, L. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02560-w · Cited by 4
Drummond, R. F., Seif, K. E., Higgs, A. J., & Reece, E. A. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.08.088 · Cited by 3
Thijs, I., Siegelaar, S. E., Elhenawy, Y. I., Benhalima, K., Pinhas‐Hamiel, O., van den Heuvel, T. R. A., Castañeda, J., & Cohen, O. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70377 · Cited by 3
Donovan, L., Lemieux, P., Yamamoto, J. M., Dunlop, A. D., Murphy, H. R., Liu, S., Chaput, K. H., Simmons, D. S., Bell, R. C., Benham, J. L., et al. (2026) · Diabetes Care · doi:10.2337/dc26-0470 · Cited by 4
Self-citationMcGill, J. B., Donihi, A. C., Aktürk, H. K., Freeby, M., Gupta, A., Horton, W. B., Jadoon, M. N., Lathief, S., Miracle-López, S., Tan, C., et al. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.06.011 · Cited by 3
Schipper, S. B. J., Karagiannis, T., Zaccardi, F., Remmelzwaal, S., Blom, M. T., Dagan, N., Schoonmade, L. J., Langendam, M. W., Mb, J., Jensen, W., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06789-0 · Cited by 4
Medina, A. M. G., Carrillo, D. C. H., Macías, M. N. S., Soto-Chávez, M. J., Gómez, M. A. R., Parra, D., González, J. A. G., Grassi, B. A., Imitola, A., Cob, A., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111902 · Cited by 5
Nofal, A. A., Benkhadra, K., Abbas, A. S., Nduwimana, M.-J., Al-Kordi, M., Allababidi, A. K., Wyckoff, J., Lapolla, A., Prokop, L. J., Wang, Z., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf289 · Cited by 3
EndoBridge 2024: pearls and highlights
Yıldız, B. O., Armeni, E., Balodimou, C., Biondi, B., Ciudin, A., Frühbeck, G., Fuleihan, G. E., Geer, E. B., Gillard, P., Gordon, C. M., et al. (2025) · HORMONES · doi:10.1007/s42000-025-00708-5 · Cited by 4
Use of advanced technology for the treatment of type 1 diabetes in pregnancy
Geerts, I., & Benhalima, K. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102026 · Cited by 3
Knorr, S., Aalders, J., Overgaard, M., Støvring, H., Mathiesen, E. R., Damm, P., Clausen, T. D., Christensen, U. B., Andersen, L. L. T., Vinter, C. A., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082237 · Cited by 4
New exploration on pathogenesis and early diagnosis of gestational diabetes
Bai, H. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i1.93826 · Cited by 3
Mendoza, L. C., Cohen, O., Smaniotto, V., & Corcoy, R. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112047 · Cited by 2
Jones, C. H., Morrison, A., Grudgings, G., Evans, S., Hamza, M., Thayyil, S., Dales, J., Morgan, H. D., Lawrence, I. G., Maybury, H., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251338863 · Cited by 4
Yang, D., Ling, P., Wang, C., Zheng, X., Deng, H., Yang, X., Yan, J., Xu, W., Luo, S., & Weng, J. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70048 · Cited by 2
Diabetes Technology Use in Pregnancies with Type 1 Diabetes in the United States from 2009 to 2020
Sobhani, N. C., Huang, Y., Venkatesh, K. K., Wright, J. D., Friedman, A. M., & Wen, T. (2025) · American Journal of Perinatology · doi:10.1055/a-2625-6437 · Cited by 2
Ronald, C. W., Chow, E. W., Ng, N. Y. H., Sugiyama, T., Deng, Y., Tam, W. H., Lau, S., Poon, L. C., Zhang, C., & Sriram, U. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70095 · Cited by 3
A call for a multidisciplinary intervention to address severe insulin resistance during pregnancy
Young, C. F., & Isaacs, D. M. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01164-2 · Cited by 2
Caretto, A., Mugnozza, F. S., Valsecchi, F., Pedone, E., Pozzoni, M., Rosa, S., Laurenzi, A., Frontino, G., Chimienti, R., Piemonti, L., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1639884 · Cited by 3
Optimizing Automated Insulin Delivery Systems for Pregnancy
Szmuilowicz, E. D., & Feig, D. S. (2025) · Diabetes Spectrum · doi:10.2337/dsi25-0009 · Cited by 3
Carrieri, F., BALDASSARRE, M. P. A., Coluzzi, S., Centorame, G., Consoli, A., & Formoso, G. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-08420-3 · Cited by 3
Villanueva, G., Cogo, E., Buckley, B. S., Petkovic, J., Probyn, K., McIntosh, H., Bergman, H., Christou, M., Pelone, F., Kazi, F., et al. (2026) · Pregnancy · doi:10.1002/pmf2.70224 · Cited by 2
Hamer, J., Man, R., Adeoye, A., Amaranathan, S., Massey, S., Gurney, L., Morris, R. K., & Morton, V. H. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2026.115122 · Cited by 2
Advances in diabetes technology: clinical implications, limitations, and future perspectives
Apostolopoulou, M., & Effraimidis, G. (2026) · HORMONES · doi:10.1007/s42000-026-00797-w · Cited by 2
Ghaur, S. Y., Grinderslev, P. B., Leth‐Møller, M., Ovesen, P., Fuglsang, J., Fisker, S., McIntyre, D. H., & Kampmann, U. (2024) · Reproductive Medicine · doi:10.3390/reprodmed5010002 · Cited by 2
Yoo, J. H., Kim, J. Y., & Kim, J. H. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0039 · Cited by 4
Diabetes Care for the Aging Population in the Digital Age
Munshi, M. N., & Toschi, E. (2024) · NEJM Evidence · doi:10.1056/evide2400389 · Cited by 2
Artificial Pancreas: The First 20 Years*
Doyle, F. J., & Kovatchev, B. P. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0134 · Cited by 4
Management of pre-gestational diabetes in pregnancy
Scott, R. (2024) · Medicine · doi:10.1016/j.mpmed.2024.07.007 · Cited by 1
Hypoglycemia in Pregnant Women with Type 1 Diabetes: Is It Inevitable?
Rosenn, B., Khoury, J. C., Mimouni, F. B., Ehrlich, S. R., & Miodovnik, M. (2024) · American Journal of Perinatology · doi:10.1055/a-2442-7305 · Cited by 1
Impact of Intensive Insulin Stabilisation Service in Pregnancy with Type 1 Diabetes
Teasdale, S., Cannon, N., Griffin, A., Nisbet, J. C., & McIntyre, D. H. (2024) · Reproductive Medicine · doi:10.3390/reprodmed5040026 · Cited by 1
Fan, W., Deng, C., Zhou, Z., & Li, X. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0282 · Cited by 1
Supported Open-Source Automated Insulin Delivery for Management of Type 1 Diabetes in Pregnancy
Hawke, K., Kabootari, M., & Elliott, T. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251336779 · Cited by 1
National trends in offspring birth size in pregnancies with maternal type 1 diabetes in Sweden
Sandin, S., Järnbert‐Pettersson, H., Simmons, D. S., BACKMAN, H. E., & Persson, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112350 · Cited by 1
Artificial Pancreas: The First 20 Years
Doyle, F. J., & Kovatchev, B. P. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251330920 · Cited by 5
Advantages and Challenges of Automated Insulin Delivery Use in Pregnancy: Physiology Considerations
Valent, A. M., & Powe, C. E. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251359652 · Cited by 1
Role of Telehealth in an Obstetrician-Gynecologist’s Workplace
Moon, L. M., & Maxted, M. E. (2025) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2025.07.008 · Cited by 1
Geerts, I., Beunen, K., Peeters, M., Wilder, N. V., Ballaux, D., Vanhaverbeke, G., Taes, Y., Aers, X.-P., Nobels, F. R. E., Huffel, L. V., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251379505 · Cited by 1
Swiss Diabetes and Technology recommendations
Gastaldi, G., Bally, L., Burckhardt, M., Gamarra, E., Hauschild, M., Konrad, D., Lehmann, R., Piazza, C. D., Savet, M., Schwitzgebel, V., et al. (2025) · Swiss Medical Weekly · doi:10.57187/s.4632 · Cited by 1
Automated Insulin Delivery in Pregnancy
Polsky, S. (2025) · JAMA · doi:10.1001/jama.2025.19201 · Cited by 1
A Review of Automated Insulin Delivery Use in Type 1 Diabetes During Pregnancy
Young, E., Goyette, A. R., Alkire, J. F., Khachemoune, N. L., Bellini, N. J., & Isaacs, D. M. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.10.015 · Cited by 1
Rizvi, S. R., Desjardins, D., Kaur, R. J., Wood‐Wentz, C. M., Crusan, D. J., Reid, C. L., Trinidad, M. C., Bailey, K. R., & Kudva, Y. C. (2025) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2025.100664 · Cited by 1
Automated Insulin Delivery Beyond Glycemic Outcomes: Endpoints and Evidence
Jones, H. C., Trawley, S. L., Jenkins, A. J., MacIsaac, R. J., Kong, Y. W., Morrison, D., & O'Neal, D. N. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251390831 · Cited by 3
Lovell, H., Wicks, E., Thompson, H., Brace, L., Stacey, T., Rayment‐Jones, H., & Harding, S. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-098926 · Cited by 1
Kirton, L. W., Cook, J., Hamill, R., Kingi, T., Kivi, N., Eathorne, A., Rogan, A., Weatherall, M., & Beasley, R. W. (2026) · Emergency Medicine Journal · doi:10.1136/emermed-2024-214023 · Cited by 1
Hossin, M. Z., Persson, M., Bjørk, M.-H., Stephansson, O., & Razaz, N. (2026) · BMC Medicine · doi:10.1186/s12916-026-04696-0 · Cited by 1
Beato-Víbora, P. I., Syleouni, M., Lee, T. T. M., Mirón, A. K., Quirós, C., Carrieri, F., Scott, E. M., & Murphy, H. R. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261423217 · Cited by 1
Self-citationBartuś, T., & Bartuś, J. (2026) · Wiadomości Lekarskie · doi:10.36740/wlek/219973 · Cited by 1
Emanuel, A. L., Sprengers, M., IJzerman, R. G., Painter, R. C., & Siegelaar, S. E. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109365 · Cited by 1
EndoBridge 2025: pearls and highlights
Yıldız, B. O., Armenti, M., Brandi, M. L., Carey, J., Carling, T., Ciudin, A., Dhatariya, K., Fountas, A., Frühbeck, G., Goulis, D. G., et al. (2026) · HORMONES · doi:10.1007/s42000-026-00804-0 · Cited by 1
Update on recent advances in technology in type 1 diabetes
Aslam, A., Thabit, H., & Leelarathna, L. (2024) · British Journal of Diabetes · doi:10.15277/bjd.2024.440 · Cited by 3
Updates in the Management of Type 1 Diabetes in Pregnancy
Mazori, A. Y., & Levy, C. J. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.05.001 · Cited by 2
Hand, J., & Levy, C. J. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251334397 · Cited by 2
Dosing Algorithms for Insulin Pumps
Çınar, A. (2025) · Diabetes Spectrum · doi:10.2337/dsi25-0004 · Cited by 1
Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes
Lee, T. T. M., Bergford, S., & Murphy, H. R. (2024) · New England Journal of Medicine · doi:10.1056/nejmc2313410 · Cited by 1
Self-citationSafe Options for the Treatment of Mothers and Babies with Pregestational Diabetes
Benhalima, K., Mathieu, C., Napoli, A., Kudva, Y. C., Cypryk, K., Hammond, P. J., Cukierman‐Yaffe, T., Cyganek, K., Divakar, H., & Hod, M. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0499 · Cited by 1
Yamamoto, J. M., & Murphy, H. R. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.8807.jmy · Cited by 1
Self-citationPersistent Neonatal Risks in Maternal Type 1 Diabetes: A Call for Improved Maternal Care
Wendel, S. B. (2025) · Acta Paediatrica · doi:10.1111/apa.70323 · Cited by 1
Gu, J., Dunlop, A. D., Donovan, L., & Chaput, K. H. (2025) · medRxiv · doi:10.1101/2025.11.17.25340428 · Cited by 1
1154 Erkrankungen der Mutter während der Schwangerschaft
(2025) · De Gruyter eBooks · doi:10.1515/9783111201559-004
Hybrid closed-loop therapy: the calm before the storm
Crabtree, T. S. J. (2023) · British Journal of Diabetes · doi:10.15277/bjd.2023.426
Automated Insulin Delivery Improves Glucose Control in Pregnancy Complicated by Type 1 Diabetes
Rosenberg, K. E. (2024) · AJN American Journal of Nursing · doi:10.1097/01.naj.0001006712.56670.f4
Automatisierte Basalinsulinabgabe bei Schwangeren mit Typ-1-Diabetes
(2024) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-2220-5929
IDRIS, I. R. (2024) · Diabetes Obesity and Metabolism Now · doi:10.1002/doi2.88
Kaur, R. J., Levy, C. J., CASTORINO, K. N., Wood‐Wentz, C. M., Rizvi, S., Özaslan, B., O’Malley, G., Trinidad, M. C., Levister, C. M., Church, M. M., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae071
Artificial Pancreas – Hybrid Closed Loop: an impending revolution
Basavaraju, N., Jones, A., & Moulik, P. K. (2024) · Independent Nurse · doi:10.12968/indn.2024.4.12
Typ-1-Diabetes – Neue Aspekte in Therapie & Technologie 2024
Schimmel, T., & Ebert, T. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01204-x
Typ-1-Diabetes und Schwangerschaft
Hummel, M., & Füchtenbusch, M. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01198-6
L’avenir des traitements du diabète
Mahmutovic, M., Berkebile, G., Guichard, C., Scheyer, N., Creton, C., & Guerci, B. (2024) · Soins · doi:10.1016/j.soin.2024.08.014
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2312-0352
Automated insulin delivery postpartum: insights from the AiDAPT study extension
O'Neal, D. N., & Ross, G. P. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00374-7
Diabetes mellitus und Schwangerschaft
Laubner, K., & Kleinwechter, H. J. (2025) · Frauenheilkunde up2date · doi:10.1055/a-2385-2307
King, J., Buschur, E., Garcetti, R., Pyle, L., Sakamoto, C., Snell‐Bergeon, J. K., Nease, E., Bartholomew, A. B. C., Dungan, K. M., & Polsky, S. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109000
New Insulins, Biosimilars, and Insulin Therapy
Biester, T., & Heinemann, L. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.8804.tor
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2499-9780
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01313-1
Preechasuk, L., Thompson, T., Avari, P., Godsland, I. F., Scott, R., Uduku, C. N., Mullins, E., Oliver, N. S., & Agha-Jaffar, R. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0477
Drug Delivery Modalities and Mechanisms
Tam, Y. T., Migliozzi, M. M., Tesar, D. B., Famili, A., Wecksler, A. T., Wichner, S. M., Sreedhara, A., & Shatz-Binder, W. (2025) · Wiley eBooks · doi:10.1002/9781394236145.ch20
Schwangerschaft und Diabetes – ein Update
Laubner, K. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01354-6
Anandhakrishnan, A., Liarakos, A. L., Dhatariya, K., Gallen, G., Choudhary, P., Lumb, A. N., Wilmot, E. G., & Hussain, S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70027
Dravecká, I. (2025) · Reproductive Medicine · doi:10.3390/reprodmed6040026
Skibińska, M., & Cypryk, K. (2026) · Ginekologia Polska · doi:10.5603/gpl.105127
Diabetes mellitus and pregnancy
Bianchi, C., Citro, F., & Bertolotto, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00286-7
Neue Therapieoptionen bei Diabetes mellitus Typ 1
Arndt, S. V. (2025) · Journal für Endokrinologie Diabetologie und Stoffwechsel · doi:10.1007/s41969-025-00289-z
Galasso, S., Piccini, S., Casarsa, V., Agus, S., & Porto, A. D. (2025) · Cureus · doi:10.7759/cureus.96075
Type 1 Diabetes: During Preconception, Pregnancy, Postpartum, Breastfeeding
Yamamoto, J. M., & Donovan, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00018-1
EndoCompass Project: Research Roadmap for Diabetes, Obesity, and Metabolism
Mathieu, C., Meireles, M., Pagotto, U., Wabitsch, M., Banerjee, I., Bartolomé, A., Battelino, T., Beck, J., Chiarelli, F., León, D. D. D., et al. (2025) · Hormone Research in Paediatrics · doi:10.1159/000549194 · Cited by 1
Schwangerschaft und Typ-1-Diabetes
Schäfer-Graf, U. M., & Hummel, M. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01393-z
Histoire, actualités et perspectives du pancréas artificiel
Hanaire, H. P. (2025) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2025.10.013
Insulin pumps and artificial pancreas
Markakis, K. P., & Vazeou, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00296-x
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meissner, T., et al. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-7979
Stessa tecnologia, diversi risultati: due gravidanze con diabete mellito di tipo 1 a confronto
Lago, A. D., & Bianchi, C. (2025) · il Diabete · doi:10.30682/ildia2504l
Metadata
- Authors
- Lee, T. T. M., Collett, C., Bergford, S., Hartnell, S., Scott, E. M., Lindsay, R. S., Hunt, K. F., McCance, D. R., Barnard-Kelly, K., Rankin, D., Lawton, J., Reynolds, R. M., Flanagan, E., Hammond, M., Shepstone, L., Wilinska, M. E., Sibayan, J., Kollman, C., Beck, R., Hovorka, R., & Murphy, H. R.
- Affiliations
- University of East Anglia (GB)
- ORCID
- Lee, Tara T.M.
- Collett, Corinne
- Bergford, Simon
- Hartnell, Sara
- Scott, Eleanor M.
- Lindsay, Robert S.
- Hunt, Katharine F.
- McCance, David R.
- Barnard-Kelly, Katharine
- Rankin, David
- Lawton, Julia
- Reynolds, Rebecca M.
- Hammond, Matthew
- Shepstone, Lee
- Wilinska, Malgorzata E.
- Sibayan, Judy
- Kollman, Craig
- Beck, Roy
- Hovorka, Roman
- Murphy, Helen R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-10-26
- Volume
- 389
- Issue
- 17
- Pages
- 1566-1578
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4387357591
- Cited by
- 241
- References
- 23
- Citations by year
- 2026: 61 · 2025: 102 · 2024: 68 · 2023: 9
- FWCI
- 49.35
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, cc-by)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Efficacy and Mechanism Evaluation Programme (NIHR EME reference 16/35/01)
- Juvenile Diabetes Research Foundation United States of America (#2-RSC-2019-828-M-N, #22-2013-266)
- Diabetes Research and Wellness Foundation (Sutherland-Earl Fellowship (reference SECF/21))
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, pregnancy, artificial pancreas, continuous glucose monitoring, glycemic control, HbA1c, time in range, hyperglycemia, hypoglycemia, maternal safety, gestational diabetes management, severe hypoglycemia, neonatal outcomes, neonatal hypoglycemia
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Pregnancy, Pregnancy in Diabetics, Blood Glucose Self-Monitoring, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.